Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.

2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 04:58 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
IRON DEFICIENCY PROFILE
Test Done Observed Value Units Biological Reference Interval
IRON DEFICIENCY PROFILE
IRON - Ferrozine 104.60 ug / dl 70 - 180
TOTAL IRON BINDING CAPACITY ( TIBC ) - Calculated 422.00 * ug / dl ADULT - 250-400
% TRANSFERRIN SATURATION - Calculated 24.79 % 13 - 45

Interpreta on : The serum iron is measured by Ferrozine method.Normal body contains 3.2 to 4.0 gms of iron.Decreased serum levels
may be seen in iron de ciency anemia and chronic in ammatory disorders.Increased levels occur in hemochromatosis,
iron poisoning and acute hepa s.The procedure is linear upto 500 ug / dl.
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 1 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 08:46 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
LIPID PROFILE
Test Done Observed Value Units Biological Reference Interval
LIPID PROFILE
Cholesterol - Oxidase,Easterase,Peroxidase 134.80 * mg / dl Desirable: < 200
Borderline High: 200-239
High: >= 250
Triglyceride - Enzyma c Endpoint 194.40 * mg / dl Normal: < 180
Borderline High: 180-229
High: 230-499
Very High: >= 500
HDL Cholesterol - Direct Measure-PEG 43.00 mg / dl No Risk- > 55
Moderate Risk - 35 to 55
High Risk - < 35
LDL Cholesterol - Calculated 52.92 mg / dl DESIRABLE :- < 130
BORDERLINE HIGH RISK :-
130 - 159
HIGH RISK :- > 160
VLDL Cholesterol - Calculated 38.88 mg / dl 0 to 40
Total Cholesterol / HDL Cholesterol Ra o - Calculated 3.13 RATIO 0.00 TO 5.00
LDL / HDL Cholesterol Ra o - Calculated 1.23 RATIO 0.00 TO 4.30

Interpreta on : Risk factor for coronary disease

Sr.Cholesterol
Low < 200 mg/dl Moderate 200 - 239 mg/dl High >240 mg/dl
Sr.LDL Cholesterol
Low < 130 mg/dl Moderate 130 - 159 mg/dl High > 160 mg/dl
Cholesterol /HDL
Low < 5.1 mg/dl Moderate 5.1 - 8.0 High > 8.1.

As per na onal cholesterol educa on program adult treatment panel III ( NCEP ATP III ) modi able include abnormal
lipid pro le sedentary life style, smoking diet & hypertension.
Live healthy way to lead healthy life.
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 2 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 04:58 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
LIVER FUNCTION TEST
Test Done Observed Value Units Biological Reference Interval
LIVER FUNCTION TEST
Aspartate Transaminase (SGOT) - UV Without P5P 25.10 U/L 0 to 40
IFCC
Alanine Transaminase (SGPT) - UV Without P5P IFCC 19.50 U/L 0 to 45
Total Bilirubin - Diazonium Ion 0.70 mg / dl 0.0 - 1.1
Direct Bilirubin - Diazo za on 0.40 mg / dl Upto 0.60
Indirect Bilirubin - Calculated 0.30 mg / dl 0.10 - 0.80
Alkaline Phosphatase - PNPP,AMP Bu er 105.60 U/L 40 to 129
Total Protein - Biuret 7.47 g/dl 6.60 to 8.70
Albumin - Bromocresol Green (BCG) 4.84 g / dl 3.50 to 5.20
Globumin - Calculated 2.63 gm / dl 2.00 TO 4.00
A/G Ra o - Calculated 1.84 mg / dl 1-3
Gamma Glutamyl Transferase (GGT) - G-glutamyl 33.00 U/L 10 to 71
carboxy nitroanilide

Interpreta on
Comment : Results released is as the sample received

~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 3 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 04:58 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
RENAL / KIDNEY FUNCTION TEST
Test Done Observed Value Units Biological Reference Interval
RENAL / KIDNEY FUNCTION TEST
Urea - Urease- UV 25.30 mg / dl 16.00 TO 48.50
BUN - Calculated 11.82 mg / dl 6.00 to 20.00
Crea nine - Ja e 1.06 mg/dl 0.50 to 1.50
Calcium - Bapta 10.23 * mg/dl 8.80 to 10.20
Uric Acid - Uricase,UV 4.20 mg / dl 3.40 TO 7.00
Phosphorous - Phosphomolybdate-UV 9.95 * mg / dl 2.50 to 4.50

Interpreta on
Comment : Results released is as the sample received

~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 4 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 04:58 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
Serum 25(OH) - Vitamin D
Test Done Observed Value Units Biological Reference Interval
Serum 25(OH) - Vitamin D
Serum 25(OH) - Vitamin D - ECLIA 29.10 ng / ml DEFICIENCY :- < 10
MODERATE INSUFFICIENCY:
-11-20
MILD INSUFFICIENCY:-21-
25
SUFFICIENCY :- 26 - 70
TOXICITY :- > 70

Interpreta on : Interpreta on :
1. Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized in
skin from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly in dietary
sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.
2. Tes ng for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutri onal status as obtained
from sunlight exposure & dietary intake. For diagnosis of vitamin D de ciency it is recommended to have clinical
correla on with serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.
3. During monitoring of oral vitamin D therapy- suggested tes ng of serum 25(OH)vitamin D is a er 12 weeks or 3 mths
of treatment. However, the required dosage of vitamin D supplements & me to achieve su cient vitamin D levels
show signi cant seasonal(especially winter) & individual variability depending on age, body fat, sun exposure, physical
ac vity ,gene c factors(especially variable vitamin D receptor responses), associated liver or renal disease,
malabsorp on syndromes and calcium or magnesium de ciency in uencing the vitamin D metabolism Vitamin D
toxicity is known but very rare.kindly correlate clinically, repeat with fresh sample if indicated.
Associated Test Pro le :
• For diagnosis of vitamin D de ciency it is recommended to have clinical correla on with serum 25(OH)vitamin D and
serum PTH.An inverse rela onship exists between PTH and 25(OH)D levels, Parathyroid hormone levels start to rise at
25(OH)D levels below 31 ng/mL & usually decrease a er the correc on of vitamin D insu ciency.Thus, restora on of
PTH and 25(OH)D levels to normalcy a er adequate vitamin D replacement therapy is a useful monitoring strategy.
• As a holis c & scien c approach for diagnosis and op mal treatment for vitamin D de ciency, Vitamin D plus pro le
(25 Hydroxy(OH) Vit D and PTH) is suggested.
Please correlate with clinical condi ons.
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 5 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 08:46 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
SERUM ELECTROLYTES
Test Done Observed Value Units Biological Reference Interval
SERUM ELECTROLYTES
Sodium - ISE Indirect 142.0 mEq / L 135.00 TO 148.00
Potassium - ISE Indirect 4.60 mEq / L 3.50 to 5.50
Chloride - ISE Indirect 102.0 mEq / L 96.00 to 106.00

Interpreta on : Electrolytes are the minerals that help keep the body's uid levels in balance and are necessary to help the muscles
heart and other organs work properly. Electrolyte levels are some mes used to monitor treatment for condi ons like
heart failure high blood pressure and in some cases kidney failure etc. Abnormally low levels of sodium and chloride
may indicate the presence of poorly func oning kidneys that are not elimina ng enough water. Abnormally low levels of
potassium results in muscle weakness paralysis etc. Abnormally high levels of sodium chloride and potassium may
indicate dehydra on.

Reference : Clinical chemistry and molecular diagnos cs ets fundamentals of seventh rdi on.
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 6 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 05:03 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
THYROID PROFILE
Test Done Observed Value Units Biological Reference Interval
THYROID PROFILE
TOTAL TRIIDOTHYRONINE ( T3 ) 92.80 ng /dl 84.63 - 201.80
TOTAL THYROXINE ( T4 ) 6.78 ug / dl 5.13 - 14.06
ULTRASENSITIVE THYROID STIMULATING HORMONE 3.25 uIU /mL 0.27-5.50
( TSH )

Interpreta on : Method -ECLIA

INTERPRETATION
TSH T3 / FT3 T4 / FT4 Suggested Interpreta on for the Thyroid Func on Tests Pa ern Within Range Decreased Within
Range • Isolated Low T3-o en seen in elderly & associated Non-Thyroidal illness. In elderly the drop in T3 level can be
upto 25%. Raised Within Range Within Range •Isolated High TSHespecially in the range of 4.7 to 15 mIU/ml is
commonly associated with Physiological & Biological TSH Variability.
•Subclinical Autoimmune Hypothyroidism
•Intermi ent T4 therapy for hypothyroidism
•Recovery phase a er Non-Thyroidal illness"
Raised Decreased Decreased •Chronic Autoimmune Thyroidi s
•Post thyroidectomy,Post radioiodine
•Hypothyroid phase of transient thyroidi s"
Raised or within Range Raised Raised or within Range
•Interfering an bodies to thyroid hormones (an -TPO an bodies)
•Intermi ent T4 therapy or T4 overdose
•Drug interference- Amiodarone, Heparin,Beta blockers,steroids, an -epilep cs" Decreased Raised or within Range
Raised or within Range
•Isolated Low TSH -especially in the range of 0.1 to 0.4 o en seen in elderly & associated with Non-Thyroidal illness
•Subclinical Hyperthyroidism
•Thyroxine inges on" Decreased Decreased Decreased •Central Hypothyroidism
•Non-Thyroidal illness
•Recent treatment for Hyperthyroidism (TSH remains suppressed)" Decreased Raised Raised •Primary Hyperthyroidism
(Graves’ disease),Mul nodular goitre, Toxic nodule
•Transient thyroidi s:Postpartum, Silent (lymphocy c), Postviral (granulomatous,subacute, DeQuervain’s),Gesta onal
thyrotoxicosis with hyperemesis gravidarum" Decreased or within Range Raised Within Range •T3 toxicosis
•Non-Thyroidal illness
References: 1. Interpreta on of thyroid func on tests. Dayan et al. THE LANCET • Vol 357 • February 24, 2001
2. Laboratory Evalua on of Thyroid Func on,Indian Thyroid Guidelines, JAPI, January 2011,vol. 59.
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 7 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 05:03 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI98965
Specimen Type : SERUM
VITAMIN B12
Test Done Observed Value Units Biological Reference Interval
VITAMIN B12
Vitamin B12 Serum - ECLIA 129.70 * pg /ml 211 - 911

Interpreta on :

CLINICAL SIGNIFICANCE :-

Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such
as meat, eegs and milk. It is cr cal in normal DNA synthesis, which in turn a ects erythrocyte matura on and in the
forma on of myelin sheath. Vitamin B12 is used to nd out neurological abnormali es and impaired DNA synthesis
associated with macrocy c anemias.

Please correlate with clinical condi ons.

Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 8 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 08:46 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI679
Specimen Type : FLUORIDE PLASMA
FASTING BLOOD SUGAR
Test Done Observed Value Units Biological Reference Interval
FASTING BLOOD SUGAR
Fas ng Blood Sugar ( FBS ) - Hexokinase 128.50 * mg/dl Non-Diabe c : 70 – 99
Diabe c : > 125
Pre-Diabe c : 100 – 125

Interpreta on :
References : ADA(American Diabe c Associa on Guidelines 2016)
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.SHWETAMBARI THAKARE DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 9 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 05:32 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI984
Specimen Type : EDTA
COMPLETE BLOOD COUNT
Test Done Observed Value Units Biological Reference Interval
COMPLETE BLOOD COUNT
Total Leucocyte Count 9.52 x 10^3 / µL 4.0 - 10.0
Neutrophils 59.80 % 40.0 - 80.0
Lymphocytes 32.90 % 20.0 - 40.0
Monocytes 4.60 % 2.0 -10.0
Eosinophils 2.30 % 1.0 - 6.0
Basophils 0.40 * % 1.0 - 2.0
Absolute Neutrophil Count 5.69 x 10^3 / µL 2.0 - 7.0
Absolute Lymphocyte Count 3.13 x 10^3 / µL 0.80 - 4.00
Absolute Monocyte Count 0.44 x 10^3 / µL 0.12 -1.20
Absolute Eosinophil Count 0.22 x 10^3 / µL 0.02 - 0.50
Absolute Basophil Count 0.04 x 10^3 / µL 0.00 - 0.10
RBCs 5.30 10^6/uL 4.5 - 5.5
Haemoglobin 15.0 g / dl 13.0- 17.0
HEMATOCRIT(P.C.V.) 49.0 % 40.0 - 50.0
M.C.V. 92.5 83.0 - 101.0
M.C.H. 28.3 pg 27.0 - 32.0
M.C.H.C 30.6 * g / dl 31.5 - 34.5
RED CELL DISTRIBUTION WIDTH-CV (RDW-CV) 14.9 * % 11.6 - 14.0
RED CELL DISTRIBUTION WIDTH-SD (RDW-SD) 48.4 fL 35.00-56.00
Platelet count 303.0 x 10^3 / µL 150 - 410
M.P.V. 7.5 6.78 - 13.46
PLATELET DISTRIBUTION WIDTH (PDW) 15.9 9.00-17.00
PLATELETCRIT (PCT) 0.228 % 0.108-0.282

Interpreta on : Method : HB: Colorimetric Method. Total WBC: Flow Cytometry Di . Count: : Microscopic Examina on of Stained
Smear, RBC: Impedance , HCT,MCV,MCH,MCHC –Calculated, RDW-CV: Calculated , Platelets : Impedance Method.
Technique : Fully Automated Autoloader 5 part Di . Cell Counter .
All Test Results are subjected to stringent interna onal External and Internal Quality Control Protocols
Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.Patkar Rakesh DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 10 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 05:32 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI984
Specimen Type : EDTA
GLYCOSYLATED HAEMOGLOBIM PROFILE
Test Done Observed Value Units Biological Reference Interval
GLYCOSYLATED HAEMOGLOBIM PROFILE
GLYCOSYLATED HAEMOGLOBIN (HBA1C) 6.92 * % < 6.0% - NORMAL
6.0--7.0% - GOOD
CONTROL.
7.0--8.0% - FAIR CONTROL.
8.0--10% -
UNSATISFACTORY
CONTROL.
ABOVE 10% - POOR
CONTROL.
Mean Blood Glucose 151.90 * mg / dl AVERAGE BLOOD GLUCOSE
NORMAL RANGE:-
70--130 mg/dl :
EXCELLENT CONTROL.
131--160 mg/dl : GOOD
CONTROL.
161--190 mg/dl : AVERAGE
CONTROL.
191--220mg/dL : ACTION
SUGGESTED.
>221 mg/dl : PANIC
VALUE.

Interpreta on : METHOD :IMMUNOTURBIDOMETERY

A hemoglobin A1c (HbA1c) test measures the amount of blood sugar (glucose) a ached to hemoglobin. Hemoglobin is
the part of your red blood cells that carries oxygen from your lungs to the rest of your body. An HbA1c test shows what
the average amount of glucose a ached to hemoglobin has been over the past three months. It's a three-month
average because that's typically how long a red blood cell lives.

If your HbA1c levels are high, it may be a sign of diabetes, a chronic condi on that can cause serious health problems,
including heart disease, kidney disease, and nerve damage.

ANALYZER : COBAS 6000 MODULAR.

Comment : Results released is as the sample received
~~~ END OF REPORT ~~~

Dr.Patkar Rakesh DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 11 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 08:49 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SAT567679
Specimen Type : URINE
ROUTINE URINE EXAMINATION
Test Done Observed Value Units Biological Reference Interval
ROUTINE URINE EXAMINATION
Quan ty 5 ml
Colour Pale Yellow
Appearance Slighty Hazy
Deposit Absent Absent
pH Acidic
Speci c Gravity 1.025
Protein Absent Absent
Sugar Absent Absent
Ketones Absent Absent
Occult Blood Absent Absent
Bile Pigment Absent Absent
Bile Salts Absent Absent
Urobilinogen Absent Absent
Pus Cells 2-3 / HPF
Epithelial Cells 1-2 / HPF
Red Blood Cells Absent Absent
Casts Absent Absent
Crystals Absent Absent
Amorphous Materials Absent Absent
Yeast Absent Absent
Bacteria Absent Absent

Interpreta on : Method- Microscopy/Manual dipstrix

Comment : Results released is as the sample received

~~~ END OF REPORT ~~~

Dr.Patkar Rakesh DR (MRS) STUTI AGRAWAL

M.D. (Path) M.D. ( Path )

Page 12 of 13
Patient Name : MR SATISHH BUDDHARDEV Registered On : 09.10.2021 05:19 PM
Age and Gender : 60 / Years / M Sample Accepted On : 09.10.2021 10:13 PM
Referring Doctor : SELF Reported On : 10.10.2021 08:46 AM
Centre : DEVLIFESCIENCES PVT.LTD. Sample UID No.
SATI679
Specimen Type : FLUORIDE PLASMA
BIOCHEMISTRY
Test Done Observed Value Units Biological Reference Interval
POST PRANDIAL BLOOD SUGAR ( PP ) - Hexokinase 140.4 * mg/dl Non-Diabe c : 70 –
140
Diabe c : > 200
Pre-Diabe c : 141 –
199

References : ADA(American Diabetic Association Guidelines 2016)

Biochemistry

Comment : Results released is as the sample received

~~~ END OF REPORT ~~~

DR (MRS) STUTI AGRAWAL

Dr.SHWETAMBARI THAKARE
M.D. (Path) M.D. ( Path )

Page 13 of 13